ARCHIVES

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Organ Systems Meeting Canceled

November 19, 1982

NIH, NCI Being Discussions With HCFA On Reimbursement

April 26, 1996

Gramm-Rudman Cut Facing NCI Could Take $85 Million

October 20, 1989

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992